At a time when the world is searching for a vaccine for corona, the United States has developed a vaccine from mosquito saliva that will eradicate diseases transmitted by insects and mosquito bites.
Research into making a vaccine from mosquito saliva was started by the US National Institute of Allergy and Infectious Diseases, led by female scientist Jessica Manning. The purpose of this research is to develop a vaccine to treat malaria, dengue, chicken pox, Zika, yellow fever and other similar diseases.
The results of the first clinical trial of the study, published Thursday, show that the vaccine has been shown to be safe in humans, and that it has penetrated the human body and accelerated the response of antibodies and cells. done.
In the first phase of the study, 49 people were vaccinated and a few weeks later their hands were bitten by mosquitoes. After being bitten by mosquitoes, the immune systems of people who had become very active were examined.
The researchers say that the way the vaccine works is that it penetrates the human body and alerts the immune system to a protein that enters the body in the form of a mosquito bite and causes disease. In this way the immune system will adapt to the protein and the mosquito bite will be ineffective.
According to the WHO, malaria, a mosquito-borne disease, kills 400,000 people worldwide. If the mosquito-borne vaccine is successful and becomes commercially available, many diseases will soon follow. Will be permanently blocked.
